Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
Roflumilast
Medication labelRoflumilast tablets are indicated as a treatment to reduce the risk of COPD exacerbations in patients with severe COPD associated with…
Why this: Advisory · dailymed-prescription
Roflumilast tablets are indicated as a treatment to reduce the risk of COPD exacerbations in patients with severe COPD associated with chronic bronchitis and a history of exacerbations. Limitations of Use Roflumilast tablet is not a bronchodilator and is not indicated for the relief of acute bronchospasm. Roflumilast tablet 250 mcg is a starting dose, for the first 4 weeks of treatment only and is not the effective (therapeutic) dose.
- generic_name
- roflumilast
- product_names
- Roflumilast, ROFLUMILAST
- ndc
- 42571-259, 42571-369, 42571-259-30, 42571-259-90, 42571-259-05, 42571-259-32, 42571-259-17, 42571-369-83, 42571-369-30, 42571-369-90, 42571-369-05, 42571-369-32, 42571-369-11
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en